Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Phosphodiesterase inhibitors like tadalafil can reduce cell growth in BPH caused by CD8+ T cells in low androgen conditions.

Compound 7b is a promising candidate for treating benign prostatic hyperplasia and prostate cancer.

Finasteride and dutasteride reduce prostate cancer risk, but finasteride may increase higher-grade cancer risk.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

Spironolactone reduces the enzyme activity that converts testosterone to DHT, helping treat excessive hair growth in women.

All four treatments for early rheumatoid arthritis had similar and mostly mild side effects.

Lower finasteride doses had more side effects; dutasteride caused back pain; more research needed on post-finasteride syndrome.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

Changing the C-ring structure in certain compounds can make them better at blocking a specific human enzyme.

Eriocitrin and silymarin might be effective for hair loss treatment and need more research.

Finasteride may help improve certain brain function issues linked to dopamine.

Odds Ratios can be misleading; it's better to also present risk and Relative Risks for clarity.

Researchers found new potential but less potent rat enzyme inhibitors using a 3D model.

Deferasirox combined with sorafenib reduces liver cancer risk and lessens treatment side effects.

Certain medications can reduce mortality risk in COPD patients, but others can increase risks of cardiovascular issues, postoperative delirium, and other adverse effects.

Finasteride reduces sperm count and affects male reproductive function, while Epristeride does not.

5α-reductase inhibitors like finasteride may not be effective or safe for transgender individuals, and more research is needed.

A new compound may treat benign prostatic hyperplasia better than finasteride.

The correction states that the label change for Finasteride was in 2012, leading to more reports of side effects from non-healthcare people.

Cinacalcet may help treat hereditary vitamin D resistant rickets safely.

The document's conclusion cannot be provided because the document is not available or cannot be read.

Certain medications can cause serious side effects, including skin reactions, stroke, muscle disorders, tongue swelling, hair loss in women, and liver failure.

Finasteride reduces prostate size, improves urination, and slows prostate cancer progression.

The review found that women using hair loss drugs like finasteride and dutasteride rarely reported sexual side effects.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

Ritlecitinib has common side effects like headache and acne, and unexpected ones like diabetes and thyroid issues.

Finasteride modifies 5-alpha-reductases through a two-step process, affecting inhibitor potency and possibly causing side effects.

Dutasteride and finasteride can change semen and hormone levels in men.

Some gonadal hormone drugs can block filovirus entry into cells.